 | | PRD_001071 | | Name: | N~4~-(2,2-dimethylpropyl)-N~1~-{(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-aspartamide | | Formula: | C32 H41 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000290 | | Name: | BETA-SECRETASE INHIBITOR OM99-2 | | Formula: | C41 H64 N8 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001072 | | Name: | Thiocillin GE2270 analogue NVP-LFF571 | | Formula: | C60 H72 N13 O13 S6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000291 | | Name: | BETA-SECRETASE INHIBITOR NVP-AUR200 | | Formula: | C34 H61 N5 O7 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001073 | | Name: | Thiocillin GE2270 analogue NVP-LDK733 | | Formula: | C55 H64 N13 O11 S6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000292 | | Name: | BETA-SECRETASE INHIBITOR NVP-AMK640 | | Formula: | C29 H50 N6 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001074 | | Name: | Thiocillin GE2270 analogue NVP-LDI028 | | Formula: | C55 H64 N13 O10 S6 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000293 | | Name: | INHIBITOR AC-ESMD-CHO | | Formula: | C19 H32 N4 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001075 | | Name: | N-[(2S)-3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-1-({(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide | | Formula: | C32 H38 N6 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000295 | | Name: | GLU-VAL-DEHYDROXYMETHYLASPARTIC ACID INHIBITOR | | Formula: | C23 H30 Cl N3 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001076 | | Name: | "N-[(benzyloxy)carbonyl]-L-valyl-N~5~-[amino(iminio)methyl]-L-ornithyl-N-[(3R)-6-{[amino(iminio)methyl]amino}-1-fluoro-2-oxohexan-3-yl]-L-prolinamide | | Formula: | C31 H51 F N10 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000296 | | Name: | 4-amino-N-{(1R,8R,9R,13R)-16-(4-amino-2-methylpyrimidin-5-yl)-1-benzyl-8-(cyclohexylmethyl)-9-hydroxy-13-[(1S)-1-methylpropyl]-2,6,11,14-tetraoxo-3,7,12,15-tetraazahexadec-1-yl}piperidine-1-carboxamide | | Formula: | C41 H64 N10 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001077 | | Name: | Cul1WHB-Dcn1P-stapled acetylated | | Formula: | C71 H133 N17 O16 Se | | Definition date: | 2012-12-12 | | Last modified: | 2017-05-04 |
|
 | | PRD_000297 | | Name: | N-(furan-2-ylcarbonyl)-L-leucyl-L-tryptophan | | Formula: | C22 H25 N3 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000298 | | Name: | N-[(2R)-3-phenyl-2-{[L-prolyl-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}propyl]-L-phenylalanyl-L-valyltyrosine | | Formula: | C58 H72 N12 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001079 | | Name: | D-phenylalanyl-N-[(1-methylpyridinium-3-yl)methyl]-L-prolinamide | | Formula: | C21 H27 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000300 | | Name: | N-acetyl-L-isoleucyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-L-prolinamide | | Formula: | C22 H36 N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000301 | | Name: | N-(2-oxoethyl)-L-isoleucyl-L-alpha-glutamyl-N-[(1R)-2-carboxy-1-formylethyl]-L-threoninamide | | Formula: | C21 H36 N4 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001082 | | Name: | Tripeptide fluoromethyl ketone inhibitor Z-VAE(OMe)-FMK | | Formula: | C23 H32 F N3 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000306 | | Name: | KPFS-(CH2-NH)-LQF peptidomimetic inhibitor of PfPM1 | | Formula: | C49 H77 N10 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001083 | | Name: | D-phenylalanyl-N-[(1-methylpyridinium-4-yl)methyl]-L-prolinamide | | Formula: | C21 H27 N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000307 | | Name: | N-acetyl-6-ammonio-L-norleucyl-L-glutaminyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-leucinamide | | Formula: | C26 H52 Cl N9 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001084 | | Name: | D-phenylalanyl-N-[(4-chloro-1-methylpyridinium-3-yl)methyl]-L-prolinamide | | Formula: | C21 H26 Cl N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000308 | | Name: | methyl N-[(2S,3S)-3-amino-2-hydroxy-5-methylhexyl]-L-valyl-L-isoleucyl-L-phenylalaninate | | Formula: | C28 H48 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_001085 | | Name: | D-phenylalanyl-N-[(4-chloro-1-methylpyridinium-2-yl)methyl]-L-prolinamide | | Formula: | C21 H26 Cl N4 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
